We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to its industry peer Bio-Rad Laboratories stock (NYSE: BIO), a life sciences company, given its better growth prospects and comparatively lower valuation of 3.3x trailing revenues, compared to 5.7x for Bio-Rad.. more...
Chris Vermeulen sits down with Jim Goddard to discuss precious metals and crude oil’s latest moves. We’ve seen a pretty strong pullback in the last trading sessions yet may see crude oil continue to go higher. Copper miners have done exceptionally well and are primed and ready to have a pretty big rally. more...
Go to Profile
Mark as Read